SCHEMBL18727713

SCHEMBL18727713

CC1(C)CC(N/C(=N/C#N)Nc2c(Cl)cccc2Cl)C(C)(C)N1O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9902074 1.00 LMNA (0.30) LMNA
SCHEMBL16994521 1.00 LMNA (0.30) LMNA
SCHEMBL9901191 0.88 MEN1 (0.35) LMNA
SCHEMBL18727709 0.88 MEN1 (0.35) LMNA
SCHEMBL16994504 0.88 MEN1 (0.35) LMNA
SCHEMBL9903235 0.83 GRM5 (0.31) —
SCHEMBL17271378 0.83 P2RX7 (0.39) —
SCHEMBL16994512 0.83 P2RX7 (0.39) —
SCHEMBL9901650 0.83 QPCT (0.37) LMNA
SCHEMBL9901652 0.83 QPCT (0.37) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170107198-A1 MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF TISBURY PHARMACEUTICALS, INC 2017-04-20 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107198-A1 MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF NOX4, NOX1, NOS1 LMNA 2437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback